Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Thorax|February 5, 2004
Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitationS A Green, M-P Malice, W Tanaka, et al.
Environmental Research|June 11, 1991
Effects of 0.60 PPM nitrogen dioxide on circulating and bronchoalveolar lavage lymphocyte phenotypes in healthy subjectsI Rubinstein, T F Reiss, B G Bigby, et al.
Comprehensive Therapy|June 30, 2001
Use of oral montelukast in the treatment of asthmaG P Noonan, B Williams, R Angner, et al.
The American Journal of Physiology|December 11, 1989
Local mediator release after antigen challenge of a bronchial segment in allergic dogsT F Reiss, I Rubinstein, D L Emery, et al.
Archives of Internal Medicine|June 13, 1998
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study GroupT F Reiss, P Chervinsky, R J Dockhorn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 26, 2001
Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and olderB Williams, G Noonan, T F Reiss, et al.
The European Respiratory Journal|July 10, 1998
Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study GroupM J Noonan, P Chervinsky, M Brandon, et al.
The European Respiratory Journal|July 28, 2006
An oral selective M3 cholinergic receptor antagonist in COPDS Lu, D D Parekh, O Kuznetsova, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1993
Design of the Fracture Intervention TrialD M Black, T F Reiss, M C Nevitt, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthmaI De Lepeleire, T F Reiss, F Rochette, et al.
Pageof 5